688016 心脉医疗
已收盘 11-02 15:00:00
资讯
新帖
简况
股市必读：心脉医疗三季报 - 第三季度单季净利润同比增长10.31%
证券之星 · 07:31
股市必读：心脉医疗三季报 - 第三季度单季净利润同比增长10.31%
心脉医疗（688016）10月30日主力资金净卖出584.11万元
证券之星 · 10-31 08:13
心脉医疗（688016）10月30日主力资金净卖出584.11万元
国金证券：给予心脉医疗买入评级
证券之星 · 10-30
国金证券：给予心脉医疗买入评级
心脉医疗最新公告：前三季度净利润同比增长4.55%
证券之星 · 10-29
心脉医疗最新公告：前三季度净利润同比增长4.55%
微创医疗(00853)：心脉医疗科技前三季度归母净利润4.49亿元 同比增长4.55%
智通财经 · 10-29
微创医疗(00853)：心脉医疗科技前三季度归母净利润4.49亿元 同比增长4.55%
创始人常兆华辞任微创医疗董事长，微创系4家上市公司仍停牌
同花顺 · 10-26
创始人常兆华辞任微创医疗董事长，微创系4家上市公司仍停牌
心脉医疗（688016）10月19日主力资金净卖出223.64万元
证券之星 · 10-20
心脉医疗（688016）10月19日主力资金净卖出223.64万元
股市必读：心脉医疗新发布《心脉医疗：2026年半年度权益分派实施公告》
证券之星 · 10-15
股市必读：心脉医疗新发布《心脉医疗：2026年半年度权益分派实施公告》
股市必读：心脉医疗新发布《心脉医疗：2026年半年度权益分派实施公告》
证券之星 · 10-14
股市必读：心脉医疗新发布《心脉医疗：2026年半年度权益分派实施公告》
股市必读：心脉医疗（688016）9月24日董秘有最新回复
证券之星 · 09-28
股市必读：心脉医疗（688016）9月24日董秘有最新回复
心脉医疗：新产品落地放量、海外市场拓展、现有产品渗透率持续提升
证券之星 · 09-24
心脉医疗：新产品落地放量、海外市场拓展、现有产品渗透率持续提升
“微创系”4家港股公司集体停牌！
同花顺 · 09-15
“微创系”4家港股公司集体停牌！
医械龙头高价租房，5年缴超12亿，房东竟是“自己人”？
深蓝财经 · 09-09
医械龙头高价租房，5年缴超12亿，房东竟是“自己人”？
每周股票复盘：心脉医疗（688016）Q2净利降9.45%
证券之星 · 08-30
每周股票复盘：心脉医疗（688016）Q2净利降9.45%
心脉医疗（688016）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 08-28
心脉医疗（688016）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
股市必读：心脉医疗新发布《心脉医疗：关于2026年半年度利润分配预案的公告》
证券之星 · 08-27
股市必读：心脉医疗新发布《心脉医疗：关于2026年半年度利润分配预案的公告》
图解心脉医疗中报：第二季度单季净利润同比下降9.45%
证券之星 · 08-27
图解心脉医疗中报：第二季度单季净利润同比下降9.45%
微创医疗：心脉医疗科技上半年归母净利润3.22亿元 同比增加2.45%
同花顺 · 08-26
微创医疗：心脉医疗科技上半年归母净利润3.22亿元 同比增加2.45%
股市必读：心脉医疗（688016）6月26日董秘有最新回复
证券之星 · 06-29
股市必读：心脉医疗（688016）6月26日董秘有最新回复
心脉医疗：公司各生产基地产能利用率保持较高水平
证券之星 · 06-26
心脉医疗：公司各生产基地产能利用率保持较高水平
加载更多
公司概况
公司名称：
上海微创心脉医疗科技(集团)股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-07-22
主营业务：
上海微创心脉医疗科技(集团)股份有限公司的主营业务是主动脉及外周血管介入医疗器械的研发、生产、销售和服务。公司的主要产品是胸主动脉和腹主动脉覆膜支架、术中支架、外周血管支架、药物球囊扩张导管、球囊扩张导管、腔静脉滤器及滤器回收器、血栓切除装置、肿瘤栓塞微球。公司获得了2025上海专精特新企业品牌价值100强称号。
发行价格：
46.23
{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":86.34,"timestamp":1793602800000,"preClose":85.87,"halted":0,"volume":1579732,"delay":0,"changeRate":0.0055,"floatShares":123000000,"shares":123000000,"eps":4.7285,"marketStatus":"已收盘","change":0.47,"latestTime":"11-02 15:00:00","open":86.46,"high":87.19,"low":84.8,"amount":136000000,"amplitude":0.0278,"askPrice":86.35,"askSize":9,"bidPrice":86.34,"bidSize":1,"shortable":0,"etf":0,"ttmEps":4.7285,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793669400000},"marketStatusCode":5,"adr":0,"adjPreClose":85.87,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793583000000,1793590200000],[1793595600000,1793602800000]],"highLimit":94.46,"lowLimit":77.28,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":123262117,"isCdr":false,"pbRate":2.52,"roa":"--","peRate":18.25949,"roe":"10.67%","epsLYR":4.65,"committee":-0.418367,"marketValue":10642000000,"turnoverRate":0.0128,"status":0,"afterMarket":{"amount":198582,"volume":2300,"close":86.34,"buyVolume":0,"sellVolume":700,"time":1793604837746,"indexStatus":"已收盘 11-02 15:30:00","preClose":85.87},"floatMarketCap":10642000000},"requestUrl":"/m/hq/s/688016/","defaultTab":"news","newsList":[{"id":"2680831867","title":"股市必读：心脉医疗三季报 - 第三季度单季净利润同比增长10.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680831867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680831867?lang=zh_cn&edition=full","pubTime":"2026-11-02 07:31","pubTimestamp":1793575868,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年前三季度归母净利润4.49亿元，同比上升4.55%；第三季度扣非净利润1.19亿元，同比上升16.79%。第三季度单季度主营收入3.25亿元，同比上升8.2%；归母净利润1.26亿元，同比上升10.31%；扣非净利润1.19亿元，同比上升16.79%；负债率15.97%，毛利率73.91%，投资收益1126.5万元，财务费用1189.43万元。公司公告汇总心脉医疗：2026年第三季度报告2026年第三季度营业收入324,986,309.32元，同比增长8.20%；归母净利润126,203,571.92元，同比增长10.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200002003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679622648","title":"心脉医疗（688016）10月30日主力资金净卖出584.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679622648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679622648?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:13","pubTimestamp":1793405592,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，心脉医疗报收于85.87元，上涨4.21%，换手率2.05%，成交量2.53万手，成交额2.16亿元。10月30日的资金流向数据方面，主力资金净流出584.11万元，占总成交额2.7%，游资资金净流出895.3万元，占总成交额4.14%，散户资金净流入1479.41万元，占总成交额6.85%。融券方面，融券卖出1600.0股，融券偿还700.0股，融券余量4.58万股，融券余额393.05万元。心脉医疗主营业务：主动脉及外周血管介入医疗器械的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679256444","title":"国金证券：给予心脉医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2679256444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679256444?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:40","pubTimestamp":1793320846,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,何冠洲近期对心脉医疗进行研究并发布了研究报告《收入稳健增长，毛利率显著提升》，给予心脉医疗买入评级。公司三季度收入及利润实现稳步增长，主动脉及外周介入产品国内外市场拓展顺利。在外周静脉介入领域，公司 Fishhawk 一次性使用血栓切除装置顺利开展国内上市后临床应用。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为150.0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000015703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679314284","title":"心脉医疗最新公告：前三季度净利润同比增长4.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679314284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679314284?lang=zh_cn&edition=full","pubTime":"2026-10-29 23:41","pubTimestamp":1793288461,"startTime":"0","endTime":"0","summary":"心脉医疗(688016.SH)公告称，第三季度营业收入为3.25亿元，同比增长8.20%；归属于上市公司股东的净利润为1.26亿元，同比增长10.31%。前三季度营业收入为11.19亿元，同比增长10.26%；归属于上市公司股东的净利润为4.49亿元，同比增长4.55%。注：公司Q3净利润1.26亿，Q2净利润1.68亿，据此计算，Q3净利润环比下降24%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900064838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679288061","title":"微创医疗(00853)：心脉医疗科技前三季度归母净利润4.49亿元 同比增长4.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679288061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679288061?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:28","pubTimestamp":1793280494,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗(00853)发布心脉医疗科技2026年前三季度业绩，收入11.19亿元，同比增长10.26%;归属于心脉医疗科技股权持有人的净利润4.49亿元，同比增长4.55%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688016","00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678191906","title":"创始人常兆华辞任微创医疗董事长，微创系4家上市公司仍停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2678191906","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678191906?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:09","pubTimestamp":1793023740,"startTime":"0","endTime":"0","summary":"10月25日晚间，微创医疗（00853.HK）公告，自10月22日起，创始人常兆华因个人事务辞任董事及董事会主席等职位，继续留任集团首席科学官、专注前沿技术研发，并确认与董事会无意见分歧。Jona ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20261026/c681105788.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20261026/c681105788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676637830","title":"心脉医疗（688016）10月19日主力资金净卖出223.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676637830","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676637830?lang=zh_cn&edition=full","pubTime":"2026-10-20 08:22","pubTimestamp":1792455778,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，心脉医疗报收于84.87元，上涨2.49%，换手率1.02%，成交量1.26万手，成交额1.06亿元。10月19日的资金流向数据方面，主力资金净流出223.64万元，占总成交额2.11%，游资资金净流出1435.49万元，占总成交额13.55%，散户资金净流入1659.13万元，占总成交额15.66%。近5日资金流向一览见下表：心脉医疗融资融券信息显示，融资方面，当日融资买入631.06万元，融资偿还1300.28万元，融资净偿还669.22万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000005145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675321032","title":"股市必读：心脉医疗新发布《心脉医疗：2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675321032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675321032?lang=zh_cn&edition=full","pubTime":"2026-10-15 02:50","pubTimestamp":1792003821,"startTime":"0","endTime":"0","summary":"北京市嘉源律师事务所关于上海微创心脉医疗科技（集团）股份有限公司差异化分红事项之专项法律意见书上海微创心脉医疗科技（集团）股份有限公司因实施2026年半年度利润分配，拟向全体股东每10股派发现金红利13元（含税），公司回购专用账户中的股份不参与分配，构成差异化分红。截至2026年9月2日，公司总股本为123,262,117股，回购专用账户持有2,421,043股，实际参与分配股本为120,841,074股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500002019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675586369","title":"股市必读：心脉医疗新发布《心脉医疗：2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675586369","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675586369?lang=zh_cn&edition=full","pubTime":"2026-10-14 01:21","pubTimestamp":1791912068,"startTime":"0","endTime":"0","summary":"公司公告汇总心脉医疗：2026年半年度权益分派实施公告上海微创心脉医疗科技（集团）股份有限公司实施2026年半年度权益分派，每股派发现金红利1.30元（含税），股权登记日为2026年10月19日，除权（息）日和现金红利发放日均为2026年10月20日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670933409","title":"股市必读：心脉医疗（688016）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670933409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670933409?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:42","pubTimestamp":1790530930,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，心脉医疗报收于85.01元，下跌1.43%，换手率0.65%，成交量8015.0手，成交额6842.3万元。董秘最新回复投资者： 董秘您好，公司海外收入增速不错，但整体营收占比依旧偏低，放量速度不及市场期待。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669461989","title":"心脉医疗：新产品落地放量、海外市场拓展、现有产品渗透率持续提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2669461989","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669461989?lang=zh_cn&edition=full","pubTime":"2026-09-24 18:06","pubTimestamp":1790244365,"startTime":"0","endTime":"0","summary":"证券之星消息，心脉医疗(688016)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，受集采政策影响，公司已经告别过往高增长。请问管理层认为，公司重新恢复较快营收增速，需要实现哪些关键条件？内部有没有对应经营考核目标，谢谢。心脉医疗回复：尊敬的投资者您好，公司已积极布局外周及肿瘤介入等业务，加速推广海外市场，整体业务提速核心取决于新产品落地放量、海外市场拓展、现有产品渗透率持续提升等关键条件。公司内部有明确的经营目标与考核机制，管理层将持续推进目标的达成，感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400031811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667615191","title":"“微创系”4家港股公司集体停牌！","url":"https://stock-news.laohu8.com/highlight/detail?id=2667615191","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667615191?lang=zh_cn&edition=full","pubTime":"2026-09-15 11:30","pubTimestamp":1789443000,"startTime":"0","endTime":"0","summary":"9月初，由山东淄博人常兆华创办的“微创系”旗下4家港股上市公司——微创医疗（00853.HK）、微创机器人（02252.HK）、微创心通（02160.HK）、微创脑科学（02172.HK），因未按期披露2026年中 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260915/c679916147.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260915/c679916147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688016","BK0251","688351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532476","title":"医械龙头高价租房，5年缴超12亿，房东竟是“自己人”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532476","media":"深蓝财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666532476?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:59","pubTimestamp":1788955140,"startTime":"0","endTime":"0","summary":"微创医疗公告披露，5年总租金约为1.95亿美元，且须以现金按月预付。微创医疗公告显示，相关附属公司需要向回青橙支付相当于1年至2年租金的保证金。而据微创医疗公告披露，于8月20日，集团存放于回青橙的物业租赁保证金余额约为2.96亿元，租期届满或协议终止时无息退还。逾12亿元租金、近3亿元保证金背后，回青橙与“微创系”的真实关系仍待进一步厘清。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU1Njc1NjA2NA==&mid=2247599502&idx=4&sn=dca38fb00a591d8f5c78fd0270e28733&chksm=fa4bd9104e641b1cadfe1863a107ffdb1053ac941fe76c9a28fb691400ca1ee978f8234cb209&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1574","02252","BK0251","BK1617","00853","BK1583","02160","BK1100","688016","BK1585","BK1589","688351","02172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663458010","title":"每周股票复盘：心脉医疗（688016）Q2净利降9.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663458010","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663458010?lang=zh_cn&edition=full","pubTime":"2026-08-30 03:31","pubTimestamp":1788031870,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，心脉医疗报收于90.43元，较上周的92.46元下跌2.2%。本周，心脉医疗8月24日盘中最高价报92.8元。本周关注点来自业绩披露要点：2026年第二季度归母净利润1.68亿元，同比下降9.45%。来自股本股东变化：截至2026年6月30日股东户数为1.62万户，较上期减少0.66%。第二季度单季度主营收入4.24亿元，同比上升10.85%；单季度归母净利润1.68亿元，同比下降9.45%；单季度扣非净利润1.48亿元，同比下降0.01%。现金分红占上半年净利润比例为48.73%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662360900","title":"心脉医疗（688016）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662360900","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662360900?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:16","pubTimestamp":1787869005,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期心脉医疗发布2026年中报。截至本报告期末，公司营业总收入7.94亿元，同比上升11.13%，归母净利润3.22亿元，同比上升2.45%。本报告期心脉医疗公司应收账款体量较大，当期应收账款占最新年报归母净利润比达80.67%。去年的净利率为41.07%，算上全部成本后，公司产品或服务的附加值极高。本文数据来源于心脉医疗2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800010888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662747816","title":"股市必读：心脉医疗新发布《心脉医疗：关于2026年半年度利润分配预案的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662747816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662747816?lang=zh_cn&edition=full","pubTime":"2026-08-27 05:10","pubTimestamp":1787778623,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，心脉医疗报收于92.21元，上涨0.9%，换手率0.95%，成交量1.17万手，成交额1.08亿元。公司公告汇总：拟以实施权益分派股权登记日总股本扣减回购专用证券账户股份为基数，向全体股东每10股派发现金红利13.00元（含税）。公司公告汇总：2026年半年度营业总收入79,394.90万元，同比增长11.13%；归母净利润32,236.24万元，同比增长2.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760746","title":"图解心脉医疗中报：第二季度单季净利润同比下降9.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662760746?lang=zh_cn&edition=full","pubTime":"2026-08-27 01:55","pubTimestamp":1787766925,"startTime":"0","endTime":"0","summary":"证券之星消息，心脉医疗2026年中报显示，上半年度公司主营收入7.94亿元，同比上升11.13%；归母净利润3.22亿元，同比上升2.45%；扣非净利润2.99亿元，同比上升10.45%；其中2026年第二季度，公司单季度主营收入4.24亿元，同比上升10.85%；单季度归母净利润1.68亿元，同比下降9.45%；单季度扣非净利润1.48亿元，同比下降0.01%；负债率13.72%，投资收益642.83万元，财务费用564.63万元，毛利率71.36%。财报数据概要请见下图:本文数据来源于心脉医疗2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700005739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108247","title":"微创医疗：心脉医疗科技上半年归母净利润3.22亿元 同比增加2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108247","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662108247?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:11","pubTimestamp":1787753460,"startTime":"0","endTime":"0","summary":"微创医疗(00853)发布公告，公司附属公司上海微创心脉医疗科技(集团)股份有限公司(心脉医疗科技)截至2026年6月30日止6个月取得收入人民币7.94亿元，同比增加11.13%;归属于心脉医疗科技股权持 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260826/c679319386.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260826/c679319386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343471","title":"股市必读：心脉医疗（688016）6月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647343471?lang=zh_cn&edition=full","pubTime":"2026-06-29 03:34","pubTimestamp":1782675252,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，心脉医疗报收于86.08元，下跌2.8%，换手率1.09%，成交量1.34万手，成交额1.16亿元。董秘最新回复投资者： 公司一季报的毛利率上升很多，请问具体是哪类产品的毛利率上升较快?年报显示公司国内业务毛利率超 70%，海外业务毛利率已提升至 60% 以上。当日关注点交易信息汇总：6月26日主力资金净流出802.82万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900001106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353226","title":"心脉医疗：公司各生产基地产能利用率保持较高水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646353226?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:30","pubTimestamp":1782466241,"startTime":"0","endTime":"0","summary":"证券之星消息，心脉医疗(688016)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的产能利用率是多少？订单情况如何？前几年公司的产能利用率都超过100%，如今是什么限制了公司销售收入的增加？心脉医疗回复：尊敬的投资者您好，公司各生产基地产能利用率保持较高水平，能够满足订单需求，公司2025年年度、2026年第一季度营业收入均同比增长，公司将持续积极推进产能配套建设，提升产线运营效率，挖掘长期增长空间，感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600032037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688016","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793632943431,"stockEarnings":[{"period":"1week","weight":-0.0023},{"period":"1month","weight":0.0198},{"period":"3month","weight":-0.0671},{"period":"6month","weight":-0.1395},{"period":"1year","weight":-0.1195},{"period":"ytd","weight":-0.0394}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"17018人(较上一季度增加5.03%)","perCapita":"7243股","listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","registeredCapital":"12326万元","survey":" 上海微创心脉医疗科技(集团)股份有限公司的主营业务是主动脉及外周血管介入医疗器械的研发、生产、销售和服务。公司的主要产品是胸主动脉和腹主动脉覆膜支架、术中支架、外周血管支架、药物球囊扩张导管、球囊扩张导管、腔静脉滤器及滤器回收器、血栓切除装置、肿瘤栓塞微球。公司获得了2025上海专精特新企业品牌价值100强称号。","listedPrice":46.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}